2026-02-04 Purchase | 2026-02-06 7:37 pm | Eikon Therapeutics Inc. | EIKN | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital VI-A Management LLC Foresite Capital VI-A LLC 10% Owner | 55,555 | $18 | $999,990 | 1,370,260 (Indirect) | View |
2026-01-08 Purchase | 2026-01-12 9:58 pm | ALUMIS INC. | ALMS | Foresite Capital Management VI LLC Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner | 411,764 | $17 | $6,999,988 | 10,487,268 (Indirect) | View |
2025-11-21 Purchase | 2025-11-25 4:02 pm | ALUMIS INC. | ALMS | Foresite Capital Management VI LLC Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner | 72,212 | $7.38 | $532,925 | 15,778,040 (Indirect) | View |
2025-11-17 Purchase | 2025-11-19 8:52 pm | ALUMIS INC. | ALMS | Foresite Capital Management VI LLC Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner | 507,874 | $6.0935 | $3,094,725 | 15,705,828 (Indirect) | View |
2025-05-02 Purchase | 2025-05-06 9:47 pm | ALUMIS INC. | ALMS | Foresite Capital Management VI LLC Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner | 45,000 | $4.4956 | $202,300 | 15,197,954 (Indirect) | View |
2024-07-01 Purchase | 2024-07-03 9:30 pm | ALUMIS INC. | ALMS | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Management VI LLC Foresite Capital Fund VI LP Labs Co-Invest V LLC Foresite Labs Management I LLC Foresite Labs Fund I L.P. 10% Owner | 2,500,000 | $16 | $40,000,000 | 5,379,140 (Indirect) | View |
2024-04-03 Sale | 2024-04-05 2:15 pm | Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Opportunity Fund V L.P. 10% Owner | 13,718,311 | $0 | $0 | 0 (Indirect) | View |
2023-08-31 Sale | 2023-08-31 5:22 pm | PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. FS Development Holdings II LLC Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Foresite Capital Fund V L.P. President and CEO 10% Owner | 16,813,146 | $0 | $0 | 2,000 (Indirect Direct) | View |
2023-07-17 Purchase | 2023-07-19 2:54 pm | Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner | 700,000 | $2.97 | $2,079,000 | 1,385,825 (Indirect) | View |
2023-05-08 Purchase | 2023-05-10 5:42 pm | Kinnate Biopharma Inc. | KNTE | Foresite Capital Management IV LLC Foresite Capital Fund IV L.P. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC 10% Owner | 1,780,000 | $2.8 | $4,984,000 | 10,192,354 (Indirect) | View |
2023-04-05 Purchase | 2023-04-06 9:08 pm | PARDES BIOSCIENCES INC. | PRDS | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Tananbaum James B. 10% Owner | 773,952 | $1.5 | $1,160,928 | 13,583,762 (Indirect) | View |
2022-12-29 Purchase | 2023-01-03 4:24 pm | Theseus Pharmaceuticals Inc. | THRX | Foresite Capital Management V LLC Foresite Capital Fund V L.P. Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Tananbaum James B. 10% Owner | 500,000 | $5 | $2,500,000 | 1,209,275 (Indirect) | View |
2022-12-01 Purchase | 2022-12-05 4:24 pm | PARDES BIOSCIENCES INC. | PRDS | Foresite Capital Management V LLC Tananbaum James B. Foresite Capital Fund V L.P. 10% Owner | 637,420 | $0.85 | $541,807 | 12,809,810 (Indirect) | View |
2021-12-22 Purchase | 2021-12-23 4:52 pm | PARDES BIOSCIENCES INC. | PRDS | Tananbaum James B. Foresite Capital Fund V L.P. Foresite Capital Management V LLC Foresite Capital Opportunity Fund V L.P. Foresite Capital Opportunity Management V LLC Director 10% Owner | 325,000 | $10 | $3,250,000 | 325,000 (Indirect) | View |
2021-02-19 Purchase | 2021-02-23 5:34 pm | FS Development Corp. II | FSII | FS Development Holdings II LLC Foresite Capital Fund V L.P. Foresite Capital Management V LLC Tananbaum James B. 10% Owner | 602,500 | $10 | $6,025,000 | 602,500 (Direct) | View |